Mizuho Maintains Outperform Rating on Chemours, Lowers Price Target to $18
Sep 30, 2026
Mizuho maintained its Outperform rating for Chemours but lowered the price target to $18 due to market challenges, noting the stock remains moderately undervalued.
Show all 119 updates